![Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/da540c7125123768b0eeab52201790372885ddba/2-Table1-1.png)
Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar
Gamma Omega Chapter of Alpha Kappa Alpha Sorority, Inc. - Understanding Medications: Mixing meds and side effects, Safe medication disposal, Prescription Expiration Dates, Drug Interactions MeetingID: 845 6049 2103 Password: Care2021 <OR>
![Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA) Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/images/valenza_zamarripa_fig_2.gif)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
![Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/067b22436f475a7fe6209c314a4fa942dd154a0f/3-TableII-1.png)
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
![MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats | Semantic Scholar MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/09c4487b8ffd4eca1ee43b7451cc09f43e3e1d16/8-Figure5-1.png)
MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats | Semantic Scholar
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J) | PLOS ONE
![Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA) Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/styles/content_image_medium/public/images/valenza_zamarripa_promo.jpg?itok=HRbtRBEw)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
![PDF) Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects PDF) Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects](https://i1.rgstatic.net/publication/26656056_Combination_of_Low-dose_Nalbuphine_and_Morphine_in_Patient-controlled_Analgesia_Decreases_Incidence_of_Opioid-related_Side_Effects/links/582e988e08ae004f74bce82d/largepreview.png)
PDF) Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)